Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2011 1
2014 1
2015 2
2018 3
2020 4
2021 2
2022 5
2023 4
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

18 results

Results by year

Filters applied: . Clear all
Page 1
A Phase 3 Trial of Luspatercept in Patients with Transfusion-Dependent β-Thalassemia.
Cappellini MD, Viprakasit V, Taher AT, Georgiev P, Kuo KHM, Coates T, Voskaridou E, Liew HK, Pazgal-Kobrowski I, Forni GL, Perrotta S, Khelif A, Lal A, Kattamis A, Vlachaki E, Origa R, Aydinok Y, Bejaoui M, Ho PJ, Chew LP, Bee PC, Lim SM, Lu MY, Tantiworawit A, Ganeva P, Gercheva L, Shah F, Neufeld EJ, Thompson A, Laadem A, Shetty JK, Zou J, Zhang J, Miteva D, Zinger T, Linde PG, Sherman ML, Hermine O, Porter J, Piga A; BELIEVE Investigators. Cappellini MD, et al. N Engl J Med. 2020 Mar 26;382(13):1219-1231. doi: 10.1056/NEJMoa1910182. N Engl J Med. 2020. PMID: 32212518 Clinical Trial.
Determinants of ventricular arrhythmias in sickle cell anemia: toward better prevention of sudden cardiac death.
d'Humières T, Saba J, Savale L, Dupuy M, Boyer L, Guillet H, Alassaad L, de Luna G, Iles S, Pham Hung d'Alexandry d'Orengiani AL, Zaouali Y, Boukour N, Pelinski Y, Messonnier L, Audureau E, Derbel H, Habibi A, Lellouche N, Derumeaux G, Bartolucci P. d'Humières T, et al. Among authors: de luna g. Blood. 2023 Aug 3;142(5):409-420. doi: 10.1182/blood.2022019571. Blood. 2023. PMID: 37216685
Extreme hypomagnesemia: characteristics of 119 consecutive inpatients.
Cheminet G, Clain G, Jannot AS, Ranque B, Passeron A, Michon A, De Luna G, Diehl JL, Oudard S, Cellier C, Karras A, Vedié B, Prot-Bertoye C, Pouchot J, Arlet JB. Cheminet G, et al. Among authors: de luna g. Intern Emerg Med. 2018 Dec;13(8):1201-1209. doi: 10.1007/s11739-018-1898-7. Epub 2018 Jun 27. Intern Emerg Med. 2018. PMID: 29951810
Risk factors for severe COVID-19 in hospitalized sickle cell disease patients: A study of 319 patients in France.
Arlet JB, Lionnet F, Khimoud D, Joseph L, de Montalembert M, Morisset S, Garou A, Cannas G, Cougoul P, Guitton C, Holvoet L, Odièvre MH, Cheminet G, Bartolucci P, Santin A, Bernit E, de Luna G; DREPANO COVID-19 Collaborative Group. Arlet JB, et al. Among authors: de luna g. Am J Hematol. 2022 Mar 1;97(3):E86-E91. doi: 10.1002/ajh.26432. Epub 2021 Dec 18. Am J Hematol. 2022. PMID: 34882837 Free PMC article. No abstract available.
Prognosis of patients with sickle cell disease and COVID-19: a French experience.
Arlet JB, de Luna G, Khimoud D, Odièvre MH, de Montalembert M, Joseph L, Chantalat-Auger C, Flamarion E, Bartolucci P, Lionnet F, Monnier S, Guillaumat C, Santin A. Arlet JB, et al. Among authors: de luna g. Lancet Haematol. 2020 Sep;7(9):e632-e634. doi: 10.1016/S2352-3026(20)30204-0. Epub 2020 Jun 18. Lancet Haematol. 2020. PMID: 32563282 Free PMC article. No abstract available.
Blood exchange transfusion with dexamethasone and Tocilizumab for management of hospitalized patients with sickle cell disease and severe COVID-19: Preliminary evaluation of a novel algorithm.
De Luna G, Habibi A, Odièvre MH, Guillet H, Guiraud V, Cougoul P, Carpentier B, Loko G, Guichard I, Ourghanlian C, Pawlotsky JM, Mahevas M, Limal N, Michel M, Mekontso-Dessap A, Arlet JB, Bartolucci P. De Luna G, et al. Am J Hematol. 2022 Jul;97(7):E260-E264. doi: 10.1002/ajh.26563. Epub 2022 Apr 15. Am J Hematol. 2022. PMID: 35385170 Free PMC article. No abstract available.
Thromboprophylaxis Reduced Venous Thromboembolism in Sickle Cell Patients with Central Venous Access Devices: A Retrospective Cohort Study.
Forté S, De Luna G, Abdulrehman J, Fadiga N, Pestrin O, Pham Hung d'Alexandry d'Orengiani AL, Aneke JC, Guillet H, Budhram D, Habibi A, Ward R, Bartolucci P, Kuo KHM. Forté S, et al. Among authors: de luna g. J Clin Med. 2022 Feb 23;11(5):1193. doi: 10.3390/jcm11051193. J Clin Med. 2022. PMID: 35268283 Free PMC article.
18 results